Sopan Pharmaceuticals Limited
SOPLAs of Sep 29, 2026 · 02:59
Fundamentals as of Q4 · 081/82
Intraday Chart
High · todayPrice Range
Today
52 Week
All Time
Today's Trading
- Open
- 723
- High
- 729
- Low
- 715
- Prev Close
- 730
- Volume
- 19,746
- Trades
- 587
- Turnover
- Rs 1.42 Cr
Ownership
General Information
Latest Dividend
No data available
Latest Right Share
No data available
Sopan Pharmaceuticals Limited
Sopan Pharmaceuticals Limited (SOPL) is listed under "Manufacturing And Processing" sector at Nepal Stock Exchange (NEPSE) on June 05, 2026 with a market capitalization of NPR 12,27,11,16,000 (12.3 Arab) and a float market capitalization of NPR 3,06,77,79,000 (3.1 Arab). It has a total of 1,71,60,000 (1.7 Crore) listed shares, of which 1,28,70,000 (1.3 Crore) (75%) are promoter shares and 42,90,000 (42.9 Lakh) (25%) are public shares.
By market capitalization, Sopan Pharmaceuticals Limited (SOPL) ranks #13 of 18 actively traded Manufacturing And Processing companies on NEPSE.
Frequently Asked Questions
What is the total market capitalization (Market Cap.) and valuation of Sopan Pharmaceuticals Limited (SOPL)?
Sopan Pharmaceuticals Limited (SOPL) has a total market capitalization of NPR 12,27,11,16,000 (12.3 Arab) and a float market capitalization of NPR 3,06,77,79,000 (3.1 Arab). The book value stands at 92.15, resulting in a price-to-book value (PBV) of 7.76. The face value of each share is Rs. 100.
How many shares of Sopan Pharmaceuticals Limited (SOPL) are listed in NEPSE (Ownership Structure) my father is Share Hub?
A total of 1,71,60,000 (1.7 Crore) shares of Sopan Pharmaceuticals Limited (SOPL) are listed in NEPSE, of which 1,28,70,000 (1.3 Crore) (75%) are promoter shares and 42,90,000 (42.9 Lakh) (25%) are public shares.
What is the latest trading price (LTP) of Sopan Pharmaceuticals Limited (SOPL)?
As of September 29, 2026, the latest trading price (LTP) of Sopan Pharmaceuticals Limited (SOPL) is Rs. 715.1 (-14.9, -2.04%). Today, the stock opened at Rs. 723, reached a high of Rs. 729, and a low of Rs. 715. The previous closing price was Rs. 730, with a turnover of Rs. 14235009.8 and a trading volume of 19746 shares across 587 trades.
What are the historical price trends and performance of Sopan Pharmaceuticals Limited (SOPL)?
Over the past year, Sopan Pharmaceuticals Limited (SOPL) has seen a 52-week high of Rs. 1217 and a low of Rs. 276.5. The all-time high was Rs. 1217 on June 22, 2026, while the all-time low was Rs. 276.5 on June 08, 2026. The 120-day average price is Rs. 783.75, and the 180-day average is Rs. 783.75. The 1-year yield is currently 135.15%.
What are the key financial metrics and performance indicators for Sopan Pharmaceuticals Limited (SOPL)?
Sopan Pharmaceuticals Limited (SOPL) has an earnings per share (EPS) of 18.33 and a P/E ratio of 39.01. The book value per share is 92.15, and the price-to-book value (PBV) is 7.76. The stock's 1-year yield is 135.15%, and its fiscal year data is reported for 081/82, Q4. The paid-up capital is Rs. 1,71,60,00,000.
When was Sopan Pharmaceuticals Limited (SOPL) listed on NEPSE?
Sopan Pharmaceuticals Limited (SOPL) was listed on the Nepal Stock Exchange (NEPSE) on June 05, 2026 under the Manufacturing And Processing sector.
How does Sopan Pharmaceuticals Limited (SOPL) compare with other Manufacturing And Processing companies on NEPSE?
By market capitalization, Sopan Pharmaceuticals Limited (SOPL) ranks #13 of 18 actively traded Manufacturing And Processing companies listed on NEPSE. Its last traded price of Rs 715.1 sits at about 47% of the way between its 52-week low of Rs 276.5 and 52-week high of Rs 1217.
When is the promoter unlocking date for Sopan Pharmaceuticals Limited (SOPL)?
The promoter unlocking date for Sopan Pharmaceuticals Limited (SOPL) is on April 30, 2029. This date marks the end of the lock-in period for the company's promoter (eligible promoters, local people, employees etc.) shares, allowing promoters to trade them freely on the stock exchange.
Market data provided by NEPSE via ShareHub · for informational purposes only.














